A pre-launch AI company developing a content automation platform for the healthcare and life sciences sector partnered with Startupr to validate its go-to-market strategy through outbound acquisition. The platform used verified medical data sources to help healthcare organizations and research teams produce compliant, high-quality written content more efficiently.

The startup needed to identify its ideal customer profile, establish early traction, and build awareness before the full product launch.

The Challenge

As an early-stage company without an internal sales team, the client needed help building structure around market research, targeting, and outreach.

Limited Internal Resources
The founding team had strong technical expertise but lacked the capacity to handle outbound operations or lead generation.

Unclear Target Market
Initial campaigns lacked focus, targeting multiple industries without understanding which audience segments were most receptive.

Pre-Launch Messaging Limitations
Because the product was still in beta, outreach required creativity to build interest without relying on full product demos.

Reactivating Dormant Leads
Earlier outreach efforts had generated interest but failed to convert, leaving a valuable list of disengaged contacts that required a new approach.

Startupr’s Approach

Startupr designed a performance-based market validation program that combined rapid testing, structured experimentation, and complete transparency.

Market Research and ICP Development
Our team conducted short, data-driven outreach tests across several verticals. The results revealed that healthcare marketing teams, medical technology companies, and research institutions were the most responsive audiences.

Personalized Messaging Frameworks
Once the ideal customer profile was defined, we created customized messaging focused on credibility, compliance, and workflow efficiency, three consistent pain points within the target market.

Continuous Optimization
Each week we tested new messaging angles, subject lines, and calls to action. The tone and content evolved as the product matured, helping increase reply rates and conversions as launch approached.

Lead Reactivation Campaign
We reintroduced the platform to previously engaged prospects with updated positioning and proof of product value. This helped recover relationships that had gone cold and led to a strong share of new meetings.

Performance Transparency
All campaign data was shared through live dashboards that tracked open rates, replies, and booked meetings. The client had a clear view of performance every step of the way.

Results

93 qualified meetings booked within eight months.
23 meetings secured in the record month.
47 percent reply rate across active sequences.
88 percent open rate achieved through deliverability improvements.
43 percent of meetings came from re-engaged prospects.
1,700 new leads generated per month at campaign peak.
107 percent of KPIs achieved by the end of the engagement.

The campaign delivered measurable traction and validated the platform’s positioning before launch.

Why It Worked

Data-driven experimentation allowed the team to identify ideal audiences and adjust quickly to what worked.
Collaborative positioning framed the startup as an innovation partner rather than a traditional SaaS vendor.
List accuracy and deliverability management produced engagement rates rarely seen in cold outreach.
Accountability through performance-based pricing ensured both teams focused on outcomes rather than activity.
Transparent reporting and review cycles kept all stakeholders aligned and informed throughout the engagement.

Outcome

Within eight months, Startupr helped this AI healthcare startup secure 93 qualified meetings, refine its ICP, and establish credibility with enterprise healthcare organizations before its public launch. The project proved how early-stage companies can build market traction and investor confidence through structured testing and performance-based execution.

Meetings Booked: 93
Reply Rate: 47%
Open Rate: 88%
KPI Achievement: 107%
Revenue: NDA